For this purpose, the mRNA levels of CDKN1A/p21, MDM2 and BAX were comparatively measured by quantitative RT-PCR in the untreated and Nutlin-3-treated cultures derived from each B-CLL patient. The gene discussed is CDKN1A; the disease is B-cell chronic lymphocytic leukemia.